Avantor is a Fortune 500 company with a wide range of mission-critical products and services for the biopharma industry.
David Coorey, SVP Biopharma Business Development & Commercial Operations at Avantor spoke to the PharmaSource podcast to explain more about the services they offer.
David explains how Avantor supports biopharma companies through R&D scientific discovery, to scale up and full commercial GMP manufacturing materials including custom use excipients and single use consumables.
“Avantor has evolved a unique ‘systems approach’ to designing full Fluid handling solutions for customers” says David. “We work with customers to design and optimise a solution that’s tailored to their unique manufacturing process” rather than a rigid, one-size-fits-all approach.”
Avantor operates in more than 30 countries, with 14,500 globally:
In addition, Avantor’s channel brand offers an integrated, seamless purchasing experience that is optimised for the way their customers do business.
Find out more on the Avantor website
